Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,397 | 11,757 | 12,243 | 20,715 | 18,817 |
| Receivables | 5,252 | 7,209 | 7,258 | 7,197 | 6,848 |
| Inventories | 2,857 | 3,550 | 2,405 | 2,584 | 1,995 |
| Other current assets | 0 | 0 | 0 | 900 | 900 |
| TOTAL | $25,834 | $24,024 | $23,165 | $32,227 | $31,369 |
| Non-Current Assets | |||||
| PPE Net | 13,482 | 14,165 | 13,785 | 13,226 | 12,727 |
| Intangibles | 2,418 | 2,679 | 2,758 | 2,828 | 0 |
| Other Non-Current Assets | 11,988 | 12,378 | 11,905 | 11,811 | 15,685 |
| TOTAL | $27,888 | $29,222 | $28,448 | $27,865 | $28,412 |
| Total Assets | $53,722 | $53,246 | $51,613 | $60,092 | $59,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,134 | 3,124 | 3,190 | 2,805 | 2,556 |
| Accrued Expenses | 2,891 | 2,675 | 1,890 | 2,488 | 3,159 |
| TOTAL | $5,181 | $6,825 | $5,971 | $6,297 | $6,558 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,503 | 3,740 | 3,719 | 3,745 | 3,730 |
| Deferred Revenues | 904 | 764 | 637 | 754 | 600 |
| Other Non-Current Liabilities | 0 | 1 | 70 | 379 | 696 |
| TOTAL | $5,321 | $5,784 | $5,919 | $6,367 | $6,750 |
| Total Liabilities | $10,502 | $12,609 | $11,890 | $12,664 | $13,308 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,772 | 10,772 | 10,759 | 12,155 | 12,010 |
| Common Shares | 122 | 122 | 122 | 122 | 120 |
| Retained earnings | -237,370 | -241,040 | -241,233 | -241,662 | -242,749 |
| Other shareholders' equity | 1,967 | 3,158 | 2,617 | 1,920 | 1,216 |
| TOTAL | $43,220 | $40,637 | $39,723 | $47,428 | $46,473 |
| Total Liabilities And Equity | $53,722 | $53,246 | $51,613 | $60,092 | $59,781 |